XML 23 R13.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Accrued expenses | 9 Months Ended
--- | ---
Sep. 30, 2022
Accrued Liabilities, Current [Abstract] |
Accrued expenses | Accrued expenses Accrued expenses consisted of the following as of September 30, 2022 and December 31, 2021:
(in thousands) | September 30, 2022 |  | December 31, 2021
Accrued manufacturing expenses | $ | 13,230 |  |  | $ | 8,476 |
Accrued clinical expenses | 10,972 |  |  | 7,879 |
Accrued research and non-clinical expenses | 5,811 |  |  | 3,848 |
Accrued payroll and related expenses | 9,083 |  |  | 7,319 |
Accrued professional fees | 1,822 |  |  | 909 |
Accrued other | 286 |  |  | 285 |
| $ | 41,204 |  |  | $ | 28,716 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesCurrentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration